The majority of women at high risk of developing breast cancer decide against prophylactic treatment with tamoxifen, suggest findings of a new study funded by Cancer Research UK and published in Breast Cancer Research and Treatment.
Read More
The National Institute for Health and Care Excellence has now published updated familial breast cancer guidelines which advocate the use of three medicines to reduce the risk of developing the disease.
Read More
GPs need better support in prescribing medicines that lower the risk of certain cancers, according to a new study by Cancer Research UK, published in the British Journal of General Practice.
Read More
